QVT Financial’s Mersana Therapeutics MRSN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $18.5K | Hold |
2,506
| – | – | ﹤0.01% | 37 |
|
|
2025
Q1 | $21.6K | Hold |
2,506
| – | – | ﹤0.01% | 37 |
|
|
2024
Q4 | $89.6K | Hold |
2,506
| – | – | 0.01% | 34 |
|
|
2024
Q3 | $118K | Hold |
2,506
| – | – | 0.01% | 35 |
|
|
2024
Q2 | $126K | Hold |
2,506
| – | – | 0.01% | 32 |
|
|
2024
Q1 | $283K | Hold |
2,506
| – | – | 0.02% | 32 |
|
|
2023
Q4 | $145K | Hold |
2,506
| – | – | 0.01% | 30 |
|
|
2023
Q3 | $79.6K | Hold |
2,506
| – | – | ﹤0.01% | 35 |
|
|
2023
Q2 | $206K | Hold |
2,506
| – | – | 0.01% | 36 |
|
|
2023
Q1 | $258K | Hold |
2,506
| – | – | 0.01% | 42 |
|
|
2022
Q4 | $367K | Hold |
2,506
| – | – | 0.02% | 40 |
|
|
2022
Q3 | $424K | Hold |
2,506
| – | – | 0.03% | 45 |
|
|
2022
Q2 | $289K | Hold |
2,506
| – | – | 0.02% | 55 |
|
|
2022
Q1 | $250K | Hold |
2,506
| – | – | 0.01% | 62 |
|
|
2021
Q4 | $390K | Hold |
2,506
| – | – | 0.01% | 53 |
|
|
2021
Q3 | $591K | Hold |
2,506
| – | – | 0.04% | 55 |
|
|
2021
Q2 | $851K | Hold |
2,506
| – | – | 0.06% | 50 |
|
|
2021
Q1 | $1.01M | Buy |
+2,506
| New | +$1.01M | 0.07% | 46 |
|